Literature DB >> 9971816

Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

E Mühlberger1, M Weik, V E Volchkov, H D Klenk, S Becker.   

Abstract

The members of the family Filoviridae, Marburg virus (MBGV) and Ebola virus (EBOV), are very similar in terms of morphology, genome organization, and protein composition. To compare the replication and transcription strategies of both viruses, an artificial replication system based on the vaccinia virus T7 expression system was established for EBOV. Specific transcription and replication of an artificial monocistronic minireplicon was demonstrated by reporter gene expression and detection of the transcribed and replicated RNA species. As it was shown previously for MBGV, three of the four EBOV nucleocapsid proteins, NP, VP35, and L, were essential and sufficient for replication. In contrast to MBGV, EBOV-specific transcription was dependent on the presence of the fourth nucleocapsid protein, VP30. When EBOV VP30 was replaced by MBGV VP30, EBOV-specific transcription was observed but with lower efficiency. Exchange of NP, VP35, and L between the two replication systems did not lead to detectable reporter gene expression. It was further observed that neither MBGV nor EBOV were able to replicate the heterologous minigenomes. A chimeric minigenome, however, containing the EBOV leader and the MBGV trailer was encapsidated, replicated, transcribed, and packaged by both viruses.

Entities:  

Mesh:

Year:  1999        PMID: 9971816      PMCID: PMC104478     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Characterization of the L gene and 5' trailer region of Ebola virus.

Authors:  V E Volchkov; V A Volchkova; A A Chepurnov; V M Blinov; O Dolnik; S V Netesov; H Feldmann
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

2.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 3.  Gene expression of vesicular stomatitis virus genome RNA.

Authors:  A K Banerjee; S Barik
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

4.  Glycosylation and oligomerization of the spike protein of Marburg virus.

Authors:  H Feldmann; C Will; M Schikore; W Slenczka; H D Klenk
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

5.  Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle.

Authors:  H Feldmann; E Mühlberger; A Randolf; C Will; M P Kiley; A Sanchez; H D Klenk
Journal:  Virus Res       Date:  1992-06       Impact factor: 3.303

6.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

7.  Rescue of a Sendai virus DI genome by other parainfluenza viruses: implications for genome replication.

Authors:  J A Curran; D Kolakofsky
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

8.  The 1:1 N-NS protein complex of vesicular stomatitis virus is essential for efficient genome replication.

Authors:  F M La Ferla; R W Peluso
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses.

Authors:  E Mühlberger; A Sanchez; A Randolf; C Will; M P Kiley; H D Klenk; H Feldmann
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

10.  Infectious defective interfering particles of VSV from transcripts of a cDNA clone.

Authors:  A K Pattnaik; L A Ball; A W LeGrone; G W Wertz
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

View more
  213 in total

1.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.

Authors:  Tetsuro Ikegami; Masahiro Niikura; Masayuki Saijo; Mary E Miranda; Alan B Calaor; Marvin Hernandez; Luz P Acosta; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.

Authors:  Megan L Shaw; Adolfo García-Sastre; Peter Palese; Christopher F Basler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

8.  The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Authors:  Takeshi Noda; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

9.  Architecture and regulation of negative-strand viral enzymatic machinery.

Authors:  Philip J Kranzusch; Sean P J Whelan
Journal:  RNA Biol       Date:  2012-07-01       Impact factor: 4.652

10.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.